Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Development of a Pain Rehabilitation Program for Chronic Pain After SCI

NCT07634796 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2026-10-01
Last updated
2026-06-09

Condition(s) studied

Spinal Cord InjuriesChronic PainNeuropathic PainInterprofessional Team CollaborationPain Management

Investigational drug(s) / intervention(s)

multi-modality pain management

multi-modality pain management: 8- week pain rehabilitation program. The first meeting of the program is located at a hospital facility and thereafter they will meet at a digital platform.The program include education, home exercises and group meetings. The program consists of 4 modules. 1. Physical exercise and ergonomics. 2. Structure and recovery. 3. Employment/occupation and social support. 4. ACT and coping. Each module lasts for two weeks. The program will include video material for education, home exercises and group discussions led by clinicians with long experience in pain rehabilitation and SCI.

Study summary

Pain rehabilitation programs are essential for optimal treatment of chronic pain and are usually based on the biopsychosocial model. This is, however, not standard care for people with chronic pain after a spinal cord injury (SCI) due to a biomedical focused perspective of SCI and lack of adapted programs.

The aims of this feasibility study:

1. Develop a new digital pain rehabilitation program, adapted for the needs of people living with an SCI.
2. To investigate the feasibility and acceptability of a new digital pain rehabilitation program.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * two years since injury * Stable pain medication? Exclusion Criteria: * severe cognitive impairment * Alcohol or drug abuse * does not understand Swedish

Primary outcome measure(s)

  • Recruitment rate, number recruited per quarter — At enrollment
    Continue=6 Solve=4 Stop=3
  • Number of participant with treatment-related advere events as assessed by... — From enrollment to the end of tretment at 8 weeks
  • Participant retention- Completion rates — The end of the 8- week program
    \>75% continue, 50-75% Solve, \<50% stop
  • Program Adherence — The end of the 8-week program
    Continue \>75%, solve 50-75%, stop \<50%
  • Patients' self-perceived relevance, timing and mode of delivery — >70% Continue, Solve 50-70%, Stop <50%
    Patient evaluation, satisfied patients
  • Assessment procedure acceptance- Patient evaluations, proportions of completed questionnaires — At the end of the 8-week program
    \>80% continue, 50-80% solve, \<50% stop
  • Fidelity of delivery - Process evaluations — End of the 8-week program

Trial sites (1)

FacilityCityRegionStatus
Inst. Community Medicine and Rehabilitation Umeå Sweden
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07634796 on ClinicalTrials.gov ↗ ← All trials in Sweden